UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

Proceedings of the National Academy of Sciences - PNAS, 2012-06, Vol.109 (24), p.9623-9628

2012

Volltextzugriff (PDF)

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-02, Vol.26 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-03, Vol.26 (1), p.53-53, Article 53

2024

Volltextzugriff (PDF)

Identification of novel small molecules that inhibit STAT3-dependent transcription and function

PloS one, 2017-06, Vol.12 (6), p.e0178844

2017

Volltextzugriff (PDF)

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

ACS medicinal chemistry letters, 2013-11, Vol.4 (11), p.1102-1107

2013

Volltextzugriff (PDF)

Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein

Biochemistry and cell biology, 2009-12, Vol.87 (6), p.825-833

2009

Volltextzugriff (PDF)

Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain

Bioorganic & medicinal chemistry letters, 2011-09, Vol.21 (18), p.5605-5609

2011

Volltextzugriff (PDF)

Homology Modeling of Human Uridine-5′-diphosphate-glucuronosyltransferase 1A6 Reveals Insights into Factors Influencing Substrate and Cosubstrate Binding

ACS omega, 2020-03, Vol.5 (12), p.6872-6887

2020

Volltextzugriff (PDF)

Signal transducer and activator of transcription 3 inhibitors: a patent review

Expert opinion on therapeutic patents, 2011-01, Vol.21 (1), p.65-83

2011

Volltextzugriff (PDF)

Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity

Metabolites, 2023-01, Vol.13 (2), p.151

2023

Volltextzugriff (PDF)

Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells

Nature communications, 2018, Vol.9 (1), p.250-14, Article 250

2018

Volltextzugriff (PDF)

Validating Signal Transducer and Activator of Transcription (STAT) Protein–Inhibitor Interactions Using Biochemical and Cellular Thermal Shift Assays

ACS chemical biology, 2020-07, Vol.15 (7), p.1842-1851

2020

Volltextzugriff (PDF)

Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2

Nature communications, 2015-08, Vol.6 (1), p.7871, Article 7871

2015

Volltextzugriff (PDF)

Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity

Journal of medicinal chemistry, 2012-02, Vol.55 (3), p.1047-1055

2012

Volltextzugriff (PDF)

Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma

Journal of medicinal chemistry, 2013-09, Vol.56 (18), p.7190-7200

2013

Volltextzugriff (PDF)

An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery

Biomaterials, 2012-02, Vol.33 (5), p.1500-1508

2012

Volltextzugriff (PDF)

Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition

Cancers, 2021-07, Vol.13 (14), p.3464

2021

Volltextzugriff (PDF)

TSLP as druggable target – a silver-lining for atopic diseases?

Pharmacology & therapeutics (Oxford), 2021-01, Vol.217, p.107648-107648, Article 107648

2021

Volltextzugriff (PDF)

Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

EMBO molecular medicine, 2024-07, Vol.16 (7), p.1630-1656

2024

Volltextzugriff (PDF)

Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells

Nature communications, 2019-11, Vol.10 (1), p.1-1, Article 5050

2019

Volltextzugriff (PDF)

Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer

Science signaling, 2014-04, Vol.7 (322), p.ra38

2014

Volltextzugriff (PDF)

STAT Protein Thermal Shift Assays to Monitor Protein‐Inhibitor Interactions

Chembiochem : a European journal of chemical biology, 2022-10, Vol.23 (20), p.e202200039-n/a

2022

Volltextzugriff (PDF)

NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine

Cancer research (Chicago, Ill.), 2016-09, Vol.76 (18), p.5501-5511

2016

Volltextzugriff (PDF)

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

The Journal of biological chemistry, 2022-02, Vol.298 (2), p.101531-101531, Article 101531

2022

Volltextzugriff (PDF)

Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update

Expert opinion on therapeutic patents, 2024-04, Vol.34 (4), p.1-244

2024

Volltextzugriff (PDF)

1 – 25 von 82

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Sprache

Englisch
(82)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(58)
Life Sciences & Biomedicine
(49)
Humans
(36)
Biochemistry & Molecular Biology
(17)
Animals
(16)
Female
(16)
Pharmacology & Pharmacy
(16)
Cell Line, Tumor
(15)
Chemistry, Medicinal
(14)
Medicin Och Hälsovetenskap
(14)
Stat3 Transcription Factor - Antagonists & Inhibitors
(12)
Male
(11)
Stat3
(11)
Stat3 Transcription Factor - Metabolism
(11)
Antineoplastic Agents - Pharmacology
(10)
Chemistry
(10)
Physical Sciences
(10)
Gene Expression
(9)
Mice
(9)
Models, Molecular
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Identification of novel small molecules that inhibit STAT3-dependent transcription and function

Potent Targeting of the STAT3 Protein in Brain Cancer Stem Cells: A Promising Route for Treating Glioblastoma

Molecular disruption of oncogenic signal transducer and activator of transcription 3 (STAT3) protein

Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain

Homology Modeling of Human Uridine-5′-diphosphate-glucuronosyltransferase 1A6 Reveals Insights into Factors Influencing Substrate and Cosubstrate Binding

Signal transducer and activator of transcription 3 inhibitors: a patent review

Cycloguanil and Analogues Potently Target DHFR in Cancer Cells to Elicit Anti-Cancer Activity

Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells

Validating Signal Transducer and Activator of Transcription (STAT) Protein–Inhibitor Interactions Using Biochemical and Cellular Thermal Shift Assays

Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2

Small Molecule STAT5-SH2 Domain Inhibitors Exhibit Potent Antileukemia Activity

Inhibiting Aberrant Signal Transducer and Activator of Transcription Protein Activation with Tetrapodal, Small Molecule Src Homology 2 Domain Binders: Promising Agents against Multiple Myeloma

An activatable multimodal/multifunctional nanoprobe for direct imaging of intracellular drug delivery

Oncogenic Kinase Cascades Induce Molecular Mechanisms That Protect Leukemic Cell Models from Lethal Effects of De Novo dNTP Synthesis Inhibition

TSLP as druggable target – a silver-lining for atopic diseases?

Disrupting TSLP–TSLP receptor interactions via putative small molecule inhibitors yields a novel and efficient treatment option for atopic diseases

Author Correction: Targeted NUDT5 inhibitors block hormone signaling in breast cancer cells

Dynamic reprogramming of signaling upon met inhibition reveals a mechanism of drug resistance in gastric cancer

STAT Protein Thermal Shift Assays to Monitor Protein‐Inhibitor Interactions

NUDT15 Hydrolyzes 6-Thio-DeoxyGTP to Mediate the Anticancer Efficacy of 6-Thioguanine

The antimicrobial drug pyrimethamine inhibits STAT3 transcriptional activity by targeting the enzyme dihydrofolate reductase

Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020-2022 patent update

Suchergebnisse filtern